Asia’s first post-infection death monkeypox confirmed in India. This was announced on Monday, August 1, by the Minister of Health of the state of Kerala in the southwest of the country, Vina George.
According to her, the 22-year-old young man had no other health problems. He returned to India from the United Arab Emirates (UAE), where on July 19 he took a test for monkeypox, the result of which was positive. Some time after arriving home, he had a fever. Following this, the patient was hospitalized, and later connected to a ventilator.
The young man died on July 30. Persons in contact with him are under observation.
At least four infections in India
At least four cases of monkeypox infection have been reported in India, according to AFP. More than 18,000 infections have been reported outside of Africa since early May, most of them in Europe, according to the World Health Organization (WHO).
At least three deaths outside the African continent are believed to have been associated with the disease so far: two in Spain and one in Brazil. The case recorded in India is the fourth, and the first in Asia.
Public health emergencies
On July 23, the World Health Organization (WHO) declared an outbreak of monkeypox a global emergency (ES) in public health. By that time, more than 16,000 cases were known in 75 countries. Most infections have been identified in Europe and America. Most often, men who have same-sex sex are infected, scientists from Queen Mary University of London found out.
The researchers stressed that smallpox is not a sexually transmitted infection in the traditional sense and can be contracted through any close physical contact. “However, our work shows that the majority of transmissions so far have been associated with sexual activity, primarily, but not exclusively, among men who have sex with men,” study leader John Thornhill said.
WHO recommended measures
WHO Director-General Tedros Adhanom Ghebreyesus recommended reaching out to groups where confirmed diseasestrengthen epidemiological surveillance and public health measures, improve infection prevention and control in hospitals, and accelerate research into the use of vaccines, therapeutics and other agents.